In late 2025, the livestock industry is embracing mRNA vaccine technology to combat rapidly mutating viral strains such as Avian Influenza and Swine Fever. Unlike traditional "killed" or "live-attenuated" vaccines, mRNA platforms can be updated and manufactured in a fraction of the time, allowing for a localized response to a specific farm-level outbreak. This agility is crucial for maintaining...